Project Grant P20DK140504
- This $191,160 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support a study by Dr. David Bayne at the University of California, San Francisco (UCSF) to leverage electronic health record (EHR) data to identify patients at risk of being lost to follow-up after diagnosis of urinary stone disease in the emergency department. The project aims to: (1) streamline...
- This Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA Program 93.350 provides funding of $437,761 to the University of Texas at Austin for a 2-year research project from August 2024 to July 2026. The project aims to determine if a human enzyme therapeutic that degrades cystine can prevent or slow the formation of cystine kidney stones and mitigate associated kidney pathology in a mouse model of cystinuria, a rare metabolic disorder causing...
- This federal Project Grant award of $984,000.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective of this study is to test a novel treatment, sodium glucose co-transporter-2 inhibitor medications, for prevention of recurrent idiopathic calcium phosphate kidney stones. This research aims to develop new prevention strategies to lower the high...
- This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to identify the progressive compositional, regulatory, and spatially defined signaling environments in mid to late-gestation primate nephrogenesis. The $240,978 award, granted to the Children's Hospital Medical Center in Cincinnati, Ohio, aims to leverage the...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to leverage a unique dog model to investigate the role of the protein uromodulin in kidney stone disease. The $368,500 award, effective September 1, 2024 through August 31, 2025, will support research to identify how defects in uromodulin polymerization and peptide excretion impact renal...
- This $451,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 - Child Health and Human Development Extramural Research will support research to elucidate the role of the KBTBD2 gene in bone development and its relation to the genetic disorder Short Syndrome. The key objectives are to: 1) Determine the molecular mechanism by which KBTBD2 regulates bone development through its interaction with the p85a subunit of PI3K, a key...
- This $171,639 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a "Multi-omic Investigation of Uremic Toxin Sources and Accumulation in Children with Kidney Failure" conducted by the Children's Hospital of Philadelphia (CHOP). The key objectives of this research project are to: 1) Characterize the contributions...
- This $166,740 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to conduct research on the role of urinary phosphate in the progression of chronic kidney disease (CKD). The key activities under this 5-year award include: Defining how chronic phosphaturia (high urinary phosphate levels) impacts CKD progression in a mouse model. Determining if enhancing tubular phosphate...
- This federal Project Grant award of $421,067.00, awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund research using kidney organoids to investigate the effects of in utero exposures, such as pregestational diabetes, on kidney development programs. The research aims to identify alterations to the normal differentiation of nephron progenitors and podocytes within the kidney...
- This Project Grant award of $360,836 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to improve understanding of the genetic basis of congenital obstructive uropathy (COU) and its subtypes, known as congenital anomalies of the kidney and urinary tract (CAKUT). The research conducted at the Trustees of Columbia University in the City of New York will perform the...
PERSONALIZING OUTCOMES OF NEPHROLITHIASIS IN YOUTH (PONY) - PROJECT SUMMARY - OVERALL KIDNEY STONE DISEASE (NEPHROLITHIASIS) IS CHARACTERIZED BY PAINFUL, RECURRENT SYMPTOMATIC EVENTS AND IS RISING DISPROPORTIONATELY IN YOUTH. STRUCTURAL AND SCIENTIFIC BARRIERS HAVE IMPEDED STRENGTHENING THE EVIDENCE BASE FOR MANAGEMENT OF PEDIATRIC KIDNEY STONE DISEASE. THE OVERARCHING OBJECTIVE OF THE PERSONALIZING OUTCOMES OF NEPHROLITHIASIS IN YOUTH (PONY) P20 CENTER IS TO GENERATE KNOWLEDGE THAT IMPROVES OUTCOMES FOR YOUTH WITH NEPHROLITHIASIS THROUGH AN INTENTIONAL AND FOCUSED INITIATIVE TO ACCELERATE THE RESEARCH CAREERS OF EARLY-STAGE INVESTIGATORS AND THEREBY ENHANCE THE BENIGN UROLOGY RESEARCH COMMUNITY. TO ACHIEVE THIS MISSION, THIS PROPOSAL STRENGTHENS PARTNERSHIPS AMONG DR. GREGORY TASIAN (PI AT CHILDREN'S HOSPITAL OF PHILADELPHIA, DR JONATHAN ELLISON (EARLY-STAGE INVESTIGATOR AT CHILDREN'S WISCONSIN), DR. DAVID CHU (EARLY-STAGE INVESTIGATOR AT LURIE CHILDREN'S HOSPITAL OF CHICAGO), AND DR. JING HUANG (BIOSTATISTICIAN AT CHILDREN'S HOSPITAL OF PHILADELPHIA). IN THE PROPOSED PONY P20 CENTER, WE ADDRESS CRITICAL STRUCTURAL AND SCIENTIFIC BARRIERS THAT HAVE IMPEDED STRENGTHENING THE EVIDENCE BASE FOR MANAGEMENT OF PEDIATRIC NEPHROLITHIASIS. WE WILL ACCOMPLISH OUR OBJECTIVES BY LEVERAGING THE RESOURCES GENERATED BY DR. TASIAN'S RESEARCH PROGRAM, IN PARTICULAR THE ROBUST INFRASTRUCTURE OF THE PEDIATRIC KIDNEY STONE (PKIDS) CARE IMPROVEMENT NETWORK AND DATA GENERATED BY THE NIDDK-SUPPORTED URINARY STONE DISEASE RESEARCH NETWORK. CENTRAL TO THE PONY P20 CENTER IS THE PKIDS CARE IMPROVEMENT NETWORK, WHICH WILL SUPPORT THE RESEARCH PROJECT AND PROVIDE THE MEANS TO DISSEMINATE THE KNOWLEDGE GENERATED BY THE RESEARCH DIRECTLY INTO REAL-WORLD CARE. IN AIM 1, WE WILL GENERATE NEW KNOWLEDGE RESPONSIVE TO PATIENT-IDENTIFIED GAPS IN KIDNEY STONE RESEARCH BY CONDUCTING TWO DISTINCT BUT COMPLEMENTARY RESEARCH STUDIES THAT USE DATA FROM PKIDS TRIAL, THE PREVENTION OF URINARY STONES WITH HYDRATION (PUSH) TRIAL, AND THE STUDY TO ENHANCE UNDERSTANDING OF STENT-ASSOCIATED SYMPTOMS (STENTS). IN AIM 2, WE WILL ACCELERATE THE RESEARCH CAREERS OF EARLY-STAGE INVESTIGATORS IN BENIGN UROLOGY. THE ADMINISTRATIVE CORE WILL CREATE OPPORTUNITIES FOR DRS. ELLISON AND CHU TO LEAD THE EXECUTION OF THE RESEARCH PROJECT THROUGH OPERATIONAL AND LOGISTICAL SUPPORT AS WELL AS DATA ACCESS. PKIDS WILL ALSO PROVIDE THE SCIENTIFIC ENVIRONMENT TO SUPPORT THE R01 APPLICATIONS LED BY DRS. ELLISON AND CHU THAT WILL ARISE FROM THE RESEARCH PROJECT. IN AIM 3, THE PONY P20 CENTER WILL ENHANCE THE BENIGN UROLOGY RESEARCH COMMUNITY. WE WILL SHARE OUR EXPERTISE IN STAKEHOLDER (PARTICULARLY PATIENT AND CAREGIVER) ENGAGEMENT WITH MEMBERS OF CAIRIBU OTHER BENIGN UROLOGIC RESEARCHERS. WE WILL PARTICIPATE IN EXISTING CAIRIBU FORUMS BY CONTRIBUTING OUR LESSONS LEARNED ON STAKEHOLDER ENGAGEMENT IN CLINICAL INVESTIGATION, PATIENT-CENTERED TRIAL DESIGN, AND CONCEPTUAL INNOVATIONS IN LEARNING HEALTH SYSTEMS. OVERALL, THE PONY P20 CENTER WILL GENERATE KNOWLEDGE THAT ADDRESSES CRITICAL PRIORITIES IDENTIFIED BY YOUTH WITH NEPHROLITHIASIS AND ACCELERATES THE CAREER OF EARLY-STAGE INVESTIGATORS WHO WILL BE LEADERS IN BENIGN UROLOGICAL RESEARCH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $391.0k | 4/18/25 | ||
| Not listed | $437.5k | 8/1/24 | ||
| Not listed | $437.5k | 8/1/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
FP00043855SUB0201S | ANN & Robert H Lurie Childrens Hospital Of Chicago | Project Grant P20DK140504 | $89.4k | 11/15/24 | |
FP00043855SUB0101S | The Medical College Of Wisconsin, Inc. | Project Grant P20DK140504 | $78.4k | 10/16/24 |